USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Sensirion AG

USPTO PatentsView assignee record - 87 granted patents across 48 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

RSS updates for this company

The verdict

According to USPTO PatentsView, Sensirion ranks #4,131 of 49,997 tracked US assignees by granted-patent volume, with 87 patents across 48 technology areas.

#4,131
of 49,997 US assignees by volume
Top 5%
by Innovation Score (57.1/100)
17.9
avg claims per patent
-28%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4131 · Foreign Corporation #4,131 · 87 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-SMALL 87 grants
  • TOP-DECILE #4,131/49,997
  • PHOTO-FINISH Rani Therapeutics
  • CPC-WIDE G01N · 48 areas
  • INNOV-PAR 57.1/100
  • CLAIMS-RICH 17.9 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DOWN -28% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Rani Therapeutics, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Sensirion

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Sensirion's Innovation Score is 57.1/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Sensirion's grants concentrate

Sensirion AG is a focused PatentsView assignee: 48 CPC subclasses with 75.9% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2016 (12 grants) versus a trough of 3 in 2020. By volume, Sensirion sits between Rani Therapeutics, LLC and University of Vermont and State Agricultural College.

Sensirion's three-year grant acceleration

From 2019–2021 to 2022–2024, Sensirion AG moved from 22 to 21 grants (0.95x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Sensirion's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Sensirion holds 87 patents at rank #4,134, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Sensirion

By rank, the assignees closest to #4,134 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Sensirion's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Sensirion, neither rank-band nor same-CPC leaders (those blocks stay above).

Sensirion's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

57 Top 5% higher than 95% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

2468101214 20152016201720182019202020212022202320242025 6
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Sensirion AG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 5.7%
2016 12 13.8%
2017 12 13.8%
2018 9 10.3%
2019 9 10.3%
2020 3 3.4%
2021 10 11.5%
2022 7 8.0%
2023 6 6.9%
2024 8 9.2%
2025partial year 6 6.9%

Where it ranks

Overall rank by patents

#4,131

of 49,997 tracked assignees

Innovation Score

57.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Sensirion AG's patent record in context - here's where to go next.

  • Sensirion AG's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 75.9% of its portfolio - see every assignee active in that class. Explore G01N
  • Ranked #4,131 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Sensirion AG against Rani Therapeutics, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 57.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.